Brochure
4 Jun 2024
Coriolis Pharma at a glance
PDF 2.6 MB
Coriolis is your trusted partner for drug product development and analytical services. Learn more about our expertise and services and see how we can help you with the development of your biopharmaceutical drug product. Let's develop your success together
Content provided by our supplier
Coriolis
-
DE -
2022On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Other Content from Coriolis (2)
-
News Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies
Coriolis Pharma announces the launch of a U.S. entity that allows customers to combine the convenience of a local service with the advantages of international expertise. In parallel Coriolis introduces two novel platform services for developability assessment and pre-formulation screening. -
News On-demand webinar: Analytical ultracentrifugation – A real alternative for characterization and QC analysis
Analytical Ultracentrifuation (AUC) is a highly versatile analytical method and brings valuable benefits during the research and development of (bio)pharmaceutical drug products.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance